Clinical trial

Feasibility Study of Tolerogenic Fibroblasts in Patients With Refractory Multiple Sclerosis

NCT05080270

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-09-21

PhaseEARLY_PHASE1

Study timeline

Study start (actual)2020-09-21Date precision: day

Registry last updated2021-10-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosis, Relapsing-Remittingunresolved

Multiple Sclerosisunresolved

Interventions

Tolerogenic FibroblastsBIOLOGICAL

Sponsors & collaborators

FibroBiologicslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05080270 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.